logo

Last Update

This profile was last updated on 11/23/2010 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Joshua Murtie?

Joshua Murtie

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Background Information

Employment History

Children's Hospital Inc


Web References(2 Total References)


New understanding of schizophrenia could lead to new treatment approaches - News Room - Children's Hospital Boston

espanol.childrenshospital.org [cached]

Working in a mouse model, researchers led by Gabriel Corfas, PhD, Kristine Roy, PhD, and Joshua Murtie, PhD, in the Children's Hospital Boston Programa de neurobiología now demonstrate, for the first time, that alterations in NRG1-erbB signaling induce pathologic changes in the brain's white matter.
Image courtesy Joshua Murtie, PhD, Children's Hospital Boston.


Gene Alterations Could Mean New Treatments for Schizophrenia

www.neuropsychiatryreviews.com [cached]

Using a mouse model, researchers led by Gabriel Corfas, PhD, Kristine Roy, PhD, and Joshua Murtie, PhD, of the Neurobiology Program at the Children's Hospital in Boston, found that when Neuregulin 1 (NRG1), a growth factor, and erbB4, one of its receptors, are altered, it causes pathologic changes in the brain's white matter.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory